Plan for 147 homes in Old Trafford set for green light
Homes for Trafford - a joint venture between the council and social housing provider L&Q - is the applicant. Some 10 per cent of the housing will be affordable and the homes would be predominantly three and four-bedroom largely within two to three-storey terraced housing.
There will be access for vehicles from Bold Street and Maher Gardens and separate pedestrian accesses, including from the adjacent Merlin's Park. Homes for Trafford will stump up nearly £1m towards secondary education as part of what is known as a Section 106 agreement.
READ MORE: LIVE: Travel chaos after car crashes at major roundabout and lands on rail tracks with trains STOPPED - updates
READ MORE: Police swarm area outside primary school following incident as parents picked up children
It will also donate £15,000 towards local open space provision. There will be new parking control measures covering Tamworth Street, Gladstone Court, Nelson Court, Maher Gardens and Bold Street along with a permit parking scheme.
A report to the committee describes the currently-overgrown site as in a 'priority regeneration area'. It is only about half-a-mile from Manchester city centre.
There is a shopping centre nearby at the Moss Lane West/Chorlton Road junction. 'The site is highly accessible with strong bus linkages within the area and established cycle routes through the area,' the report says.
The three tower blocks and the pub known as The Seahawk were demolished between 2013 and 2014 and the site has been sealed from public access ever since.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 days ago
- Business Wire
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.4 million for the second quarter of 2025 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $6.0 million and an operating loss of $5.8 million. For the first half of the year, net sales were $18.7 million and operating losses were $9.8 million as compared to 2024 net revenues of $13.6 million and operating losses of $8.7 million. Increased EasyPoint ® needle sales in the first six months of 2025 positively affected overall net revenues, but the lower selling price attributable to the products resulted in a reduction of the total average selling price for the periods presented. Tariffs continue to have a material impact on our results of operation and financial position. The current tariff rate on needles and syringes imported from China is 130% and the rate on other products imported from China is 30%. We spent $2.1 million on tariffs in the first six months of 2025. We are working to lessen the financial impact of tariffs and have shifted to a larger proportion production to our U.S. facility. In the first half of 2025, 38% of our products were manufactured in the U.S. as compared to 9% in the same period of 2024. We implemented reductions in force in the second and third quarters of 2025 to offset the increase in costs from higher domestic manufacturing. Our net loss for the three and six months ended June 30, 2025 was $87 thousand and $10.6 million, respectively. Our net loss for the six months ended June 30, 2025 includes an unrealized net loss on third party debt and equity investments of $5.6 million. We also received a litigation settlement of $1.9 million in the second quarter of 2025. Retractable reports the following results of operations for the three and six months ended June 30, 2025 and 2024, respectively. Further details concerning the results of operations, as well as other matters, are available in Retractable's Form 10-Q filed on August 14, 2025 with the U.S. Securities and Exchange Commission. Comparison of Three Months Ended June 30, 2025 and June 30, 2024 Domestic sales accounted for 81.3% and 83.2% of total revenues for the three months ended June 30, 2025 and 2024, respectively. Domestic revenues increased 69.3%, while domestic unit sales increased 81.8%. Domestic unit sales represented 68.9% of total unit sales for the three months ended June 30, 2025. The increase in unit sales did not translate into a proportional increase in domestic revenues, primarily due to a decrease in average selling price. The average selling price was impacted by product mix and higher transaction fees associated with distributor agreements. The average selling price reduction was significantly impacted by the increase in EasyPoint ® needle sales in relation to all products sold. International revenues for the three months ended June 30, 2025 increased 92.6% compared to the same period in 2024. However, average selling price per unit declined relative to the second quarter of 2024, primarily due to a shift in product mix. International sales for the three months ended June 30, 2025 included Easy Point Needles sold at a discount to certain international customers which reduced the overall average selling price. There remains uncertainty regarding the timing of future international orders. Overall, units sales increased 109.2%. Cost of manufactured product increased 66.1% principally due to an increase in tariffs and additional period costs related to increased domestic production activities. Royalty expense increased 39.4% primarily due to the increase in gross sales, slightly offset by a decrease in royalties payable to a shareholder under a sublicensing agreement. Tariffs are expected to continue to materially increase our costs in future periods. Approximately $561 thousand was spent on tariff expenses in the second quarter of 2025. These costs are included in Cost of manufactured product. Operating expenses decreased 6% primarily due to a decrease in bad debt expense in the second quarter of 2025 as compared to the second quarter of 2024. The loss from operations was $5.1 million compared to a loss of approximately $5.8 million for the same period last year. The decreased loss was due to a decrease in bad debt expense. The unrealized gain on debt and equity securities was $1.6 million due to the increased market values of those securities. We received a settlement payment of $1.9 million in May 2025. The provision for income taxes was $1.8 thousand as compared to a provision for income taxes of $8.3 million for the same period in 2024. The difference is primarily related to fully reserving our deferred tax asset in the second quarter of 2024. Comparison of Six Months Ended June 30, 2025 and June 30, 2024 Domestic sales accounted for 85% and 85.5% of total revenues for the six months ended June 30, 2025 and 2024, respectively. Domestic revenues increased 36.6%, while domestic unit sales increased 47.1%. Domestic unit sales represented 74.9% of total unit sales for the six months ended June 30, 2025. The increase in unit sales did not translate into a proportional increase in domestic revenues, primarily due to a decrease in average selling price. The average selling price was impacted by product mix and higher transaction fees associated with distributor agreements. The average selling price reduction was significantly impacted by the increase in EasyPoint ® needle sales in relation to all products sold. International revenues for the six months ended June 30, 2025 increased 42.8% compared to the same period in 2024. However, average selling price per unit declined relative to the first half of 2024, primarily due to a shift in product mix. International sales for the six months ended June 30, 2025 included Easy Point Needles sold at a discount to certain international customers which reduced the overall average selling price. There remains uncertainty regarding the timing of future international orders. Overall, units sales increased 62.6%. Cost of manufactured product increased 58.8% principally due to increased unit sales, an increase in tariff cost, and additional costs related to an increase in domestic manufacturing expense increased 23.4% primarily due to the increase in gross sales, slightly offset by a decrease in royalties payable to a shareholder under a sublicensing agreement. Tariffs are expected to continue to materially increase our costs in future periods. Approximately $2.1 million was spent on tariff expenses in the first six months of 2025. These costs are included in Cost of manufactured product. Operating expenses decreased 5.2% primarily due to a decrease in bad debt expense and legal and litigation fees. The loss from operations was $9.8 million compared to a loss of approximately $8.7 million for the same period last year. The decreased loss was due to lower operating expenses, but was impacted by lower gross profit. The unrealized loss on debt and equity securities was $5.6 million due to the decreased market values of those securities. We received a settlement payment of $1.9 million in May 2025. The provision for income taxes was $288 thousand as compared to a provision for income taxes of $8.4 million for the same period in 2024. The difference is primarily related to fully reserving our deferred tax asset in the second quarter of 2024. ABOUT RETRACTABLE Retractable manufactures and markets VanishPoint ® and Patient Safe ® safety medical products and the EasyPoint ® needle. The VanishPoint ® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe ® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint ® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint ® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors. For more information on Retractable, visit its website at Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements. Factors that could cause or contribute to such differences include, but are not limited to: tariffs; material changes in demand; Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.
Business Wire
4 days ago
- Business Wire
Boston Omaha Corporation Announces Second Quarter 2025 Financial Results
OMAHA, Neb.--(BUSINESS WIRE)--Boston Omaha Corporation (NYSE: BOC) (the 'Company', 'we', or 'our') announced its financial results for the second quarter ended June 30, 2025, in connection with filing its Quarterly Report on Form 10-Q with the Securities and Exchange Commission. We show summary financial data below for the second quarter of 2025 and 2024. Our Quarterly Report on Form 10-Q can be found at A supplemental presentation providing additional financial information for the second quarter of 2025 can be found on our investor relations website at We believe that it's important for shareholders to read the supplemental presentation as, in management's opinion, it provides additional information on business metrics we use in gauging the performance of each of our three principal business units and investments. (1) Investments consist of U.S. Treasury securities classified as trading securities and marketable equity securities, of which $886,831 is held by our insurance entities at June 30, 2025. Marketable equity securities excludes Sky Harbour Group Corporation ('Sky Harbour') Class A common stock as we account for our 15.4% stake (as measured at June 30, 2025) under the equity method. (2) Noncontrolling interests are primarily related to third party capital raised within our Build for Rent Fund as well as within our 24 th Street commercial real estate funds. Expand During the second quarter of fiscal 2025, 'Net Other Expense' included an unrealized loss of $10.7 million on the Sky Harbour warrants held by Boston Omaha, losses of $2.6 million within BOAM primarily related to the changes in the fair value of the remaining assets within the 24th Street Funds, and $0.6 million in interest expense. These items were partially offset by $6.1 million in income from unconsolidated affiliates mainly related to our equity method position in Sky Harbour, $2.9 million in realized gains on the sale of 509,206 shares of Sky Harbour Class A common stock, and interest and dividend income of $0.2 million. Our investment in Sky Harbour Class A common stock and warrants was valued at $84.8 million on our condensed consolidated balance sheet as of June 30, 2025. If our investment in Sky Harbour Class A common stock was accounted for at fair value based on its quoted market price (currently valued using equity method accounting), then our total investment in Sky Harbour Class A common stock and warrants would be valued at $127.2 million as of June 30, 2025. Cash inflow from operations for the six months ended June 30, 2025 was $7.1 million, compared to a cash inflow of $6.9 million for the six months ended June 30, 2024. Our book value per share was $16.88 at June 30, 2025, compared to $16.99 at December 31, 2024. As of June 30, 2025, we had 30,872,876 shares of Class A common stock and 580,558 shares of Class B common stock outstanding. As of August 12, 2025, we had 30,872,876 shares of Class A common stock and 580,558 shares of Class B common stock outstanding. About Boston Omaha Corporation Boston Omaha Corporation is a public holding company with four majority owned businesses engaged in outdoor advertising, broadband telecommunications services, surety insurance, and asset management. Forward-Looking Statements Any statements in this press release about the Company's future expectations, plans and prospects, including statements about our financing strategy, future operations, future financial position and results, market growth, total revenue, as well as other statements containing the words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' or 'would' and similar expressions, constitute forward-looking statements within the meaning of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the Company's forward-looking statements, and you should not place undue reliance on the Company's forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements the Company makes as a result of a variety of risks and uncertainties, including risks related to the Company's estimates regarding the potential market opportunity for the Company's current and future products and services, the competitive nature of the industries in which we conduct our business, general business and economic conditions, our ability to acquire suitable businesses, our ability to successfully integrate acquired businesses, the effect of a loss of, or financial distress of, any reinsurance company which reinsures the Company's insurance operations, the risks associated with our investments in both publicly traded securities and privately held businesses, our history of losses and ability to maintain profitability in the future, the Company's expectations regarding the Company's sales, expenses, gross margins and other results of operations, and the other risks and uncertainties described in the 'Risk Factors' sections of the Company's public filings with the Securities and Exchange Commission (the 'SEC') on Form 10-K for the year ended December 31, 2024, as well as other risks and uncertainties which may be described in any subsequent quarterly report on Form 10-Q filed by the Company, and the other reports the Company files with the SEC. Copies of our SEC filings are available on our website at In addition, the forward-looking statements included in this press release represent the Company's views as of the date hereof. The Company anticipates that general economic conditions and subsequent events and developments may cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof. Our investor relations website, serves as a comprehensive resource for investors. We strongly encourage its use for easy access to information about the Company. We promptly make available on this website, free of charge, the reports that we file or furnish with the SEC, corporate governance information, and select press releases, which may contain material information about us, and you may subscribe to be notified of new information posted to this site.
Business Wire
4 days ago
- Business Wire
flyExclusive Reports Second Quarter 2025 Results
KINSTON, N.C.--(BUSINESS WIRE)--flyExclusive, Inc. (NYSEAMERICAN: FLYX) today announced second quarter 2025 financial results through a Form 10-Q furnished with the Securities and Exchange Commission (SEC). The Form 10-Q can be found at or at Management will host a conference call at 5:00 pm ET today, Wednesday, August 13, 2025, to discuss the results. Interested parties can access the conference call by dialing 877-404-1250 or +1 215-268-9892 and referencing event code 13755397. To access a live webcast of the conference call, please use this link or visit the flyExclusive investor relations website at A replay of the event webcast will be available on said website for twelve months following the conclusion of the call. About flyExclusive flyExclusive is a vertically integrated, FAA-certificated air carrier providing private jet experiences by offering customers a choice of on-demand charter, Jet Club, and fractional ownership services to destinations across the globe. flyExclusive has one of the world's largest fleets of Cessna Citation aircraft, and it operates a combined total of approximately 100 jets, ranging from light to large cabin sizes. The company manages all aspects of the customer experience, ensuring that every flight is on a modern, comfortable, and safe aircraft. flyExclusive's in-house repair station, aircraft paint, cabin interior renovation, and avionics installation capabilities, are all provided from its campus headquarters in Kinston, North Carolina. To learn more, visit
